NOVARTIS AG-SPONSORED ADR (NVS) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:NVS - US66987V1098 - ADR
133.72 USD
+1.44 (+1.09%)
133.72 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.375B -1.36% | 46.66B 7.57% | 51.722B 10.85% | 56.604B 9.44% | 58.106B 2.65% | 60.166B 3.55% | 63.728B 5.92% | 66.79B 4.80% | 69.328B 3.80% | 74.245B 7.09% | 73.094B -1.55% | |
| EBITDA YoY % growth | 17.387B 1.82% | 20.919B 20.31% | 20.919B | 23.381B 11.77% | 23.842B 1.97% | 24.815B 4.08% | 30.91B 24.56% | 33.024B 6.84% | 32.184B -2.54% | 28.42B -11.70% | 26.503B -6.75% | |
| EBIT YoY % growth | 10.206B -6.91% | 12.642B 23.87% | 16.32B 29.09% | 20.971B 28.50% | 21.43B 2.19% | 22.657B 5.73% | 25.925B 14.42% | 27.523B 6.16% | 28.065B 1.97% | 28.614B 1.96% | 24.933B -12.86% | |
| Operating Margin | 23.53% | 27.09% | 31.55% | 37.05% | 36.88% | 37.66% | 40.68% | 41.21% | 40.48% | 38.54% | 34.11% | |
| EPS YoY % growth | 6.19 -2.70% | 6.98 12.75% | 7.90 13.19% | 9.23 16.95% | 9.54 3.34% | 10.40 8.96% | 11.29 8.61% | 12.35 9.35% | 12.59 1.98% | 11.76 -6.63% | 10.12 -13.95% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.02 0.82% | 2.50 8.53% | 2.32 -5.12% | 2.27 -0.27% | 1.99 -1.49% |
| Revenue Q2Q % growth | 14.106B 7.25% | 13.872B 4.83% | 13.872B -1.30% | 13.918B 0.06% | 13.398B -5.02% |
| EBITDA Q2Q % growth | 4.426B -56.30% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 4.679B 15.27% | 5.472B 14.33% | 5.324B 3.28% | 5.447B 19.69% | 4.66B -0.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.27 9.22% | 2.32 | -0.05 | -2.03% |
| Q2 2025 Q2Q % growth | 2.45 22.84% | 2.43 | 0.01 | 0.61% |
| Q1 2025 Q2Q % growth | 2.31 26.67% | 2.16 | 0.14 | 6.59% |
| Q4 2024 Q2Q % growth | 2.00 29.41% | 1.89 | 0.11 | 6.06% |
| Q3 2024 Q2Q % growth | 2.08 12.57% | 2.01 | 0.08 | 3.78% |
| Q2 2024 Q2Q % growth | 1.99 7.65% | 1.93 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.82 5.26% | 1.73 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.55 0.66% | 1.67 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.85 15.82% | 1.78 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.85 17.31% | 1.75 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.73 17.12% | 1.58 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.54 8.57% | 1.45 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.60 -7.60% | 1.60 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.58 -6.02% | 1.55 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.48 -3.95% | 1.49 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.42 4.48% | 1.46 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.73 12.50% | 1.70 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.68 22.06% | 1.59 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.54 -2.56% | 1.61 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.35 1.52% | 1.41 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.54 7.80% | 1.50 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.38 1.49% | 1.36 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.58 28.93% | 1.44 | 0.14 | 9.89% |
| Q4 2019 Q2Q % growth | 1.33 | 1.34 | -0.01 | -0.40% |
| Q3 2019 Q2Q % growth | 1.43 | 1.39 | 0.04 | 2.86% |
| Q2 2019 Q2Q % growth | 1.35 | 1.26 | 0.09 | 7.40% |
| Q1 2019 Q2Q % growth | 1.22 | 1.18 | 0.04 | 3.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.909B 8.47% | 14.312B | -403M | -2.82% |
| Q2 2025 Q2Q % growth | 14.054B 12.32% | 14.465B | -411M | -2.84% |
| Q1 2025 Q2Q % growth | 13.233B 11.87% | 13.384B | -151M | -1.13% |
| Q4 2024 Q2Q % growth | 13.153B 15.14% | 13.051B | 102M | 0.78% |
| Q3 2024 Q2Q % growth | 12.823B 8.84% | 12.994B | -171M | -1.32% |
| Q2 2024 Q2Q % growth | 12.512B -8.15% | 12.61B | -98M | -0.78% |
| Q1 2024 Q2Q % growth | 11.829B 7.08% | 11.709B | 120M | 1.02% |
| Q4 2023 Q2Q % growth | 11.423B 4.99% | 11.996B | -573M | -4.78% |
| Q3 2023 Q2Q % growth | 11.782B 9.26% | 12.001B | -219M | -1.82% |
| Q2 2023 Q2Q % growth | 13.622B -37.26% | 13.518B | 104M | 0.77% |
| Q1 2023 Q2Q % growth | 11.047B -13.79% | 12.877B | -1.83B | -14.21% |
| Q4 2022 Q2Q % growth | 10.88B 135.55% | 13.285B | -2.405B | -18.10% |
| Q3 2022 Q2Q % growth | 10.783B -19.33% | 13.106B | -2.323B | -17.72% |
| Q2 2022 Q2Q % growth | 21.712B 63.32% | 13.109B | 8.603B | 65.63% |
| Q1 2022 Q2Q % growth | 12.814B 0.95% | 12.942B | -128M | -0.99% |
| Q4 2021 Q2Q % growth | 4.619B -64.55% | 13.616B | -8.997B | -66.08% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B 2.47% | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B 0.45% | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B -3.34% | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B 11.45% | 12.249B | 459M | 3.75% |
| Q4 2019 Q2Q % growth | 12.716B | 12.517B | 199M | 1.59% |
| Q3 2019 Q2Q % growth | 12.482B | 12.065B | 417M | 3.46% |
| Q2 2019 Q2Q % growth | 12.024B | 11.752B | 272M | 2.31% |
| Q1 2019 Q2Q % growth | 11.402B | 11.601B | -199M | -1.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.97% | 0.24% | 1.55% | 0.42% |
| Revenue | -0.78% | 0.41% | 0.35% | 0.4% |